TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36316078

Group type: EXPERIMENTAL
Intervention: Complex multidisciplinary intervention to improve initial medication adherence (IMA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 35049214

Group type: EXPERIMENTAL
Intervention: Pharmacist-led medication review (intervention group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (without medication reconciliation)
Number of subjects: 100
Study: 33150399

Group type: EXPERIMENTAL
Intervention: Self-reported daytime napping
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Accelerometer-measured 'eveningness' and sleep duration, self-reported daytime sleepiness
Number of subjects: 0
Study: 33892330

Group type: EXPERIMENTAL
Intervention: Digital penetration only
Number of subjects: 109

Group type: COMPARATOR
Intervention: Penile vaginal penetration only
Number of subjects: 109
Study: 36397173

Group type: EXPERIMENTAL
Intervention: Personalized perioperative blood pressure management
Number of subjects: 1272

Group type: COMPARATOR
Intervention: Routine blood pressure management
Number of subjects: 1272
Study: 32034490

Group type: EXPERIMENTAL
Intervention: One-time colonoscopy and annual fecal immunochemical test (FIT)
Number of subjects: 9751

Group type: COMPARATOR
Intervention: Annual fecal immunochemical test (FIT)
Number of subjects: 9751

Group type: EXPERIMENTAL
Intervention: One-time colonoscopy and annual FIT
Number of subjects: 9751

Group type: COMPARATOR
Intervention: Annual FIT
Number of subjects: 9751
Study: 35704124

Group type: EXPERIMENTAL
Intervention: Text reminders generated by real-time enabled electronic monitors and data-informed counseling through 3 months postpartum (PPM3)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Text reminders and counseling
Number of subjects: 133
Study: 32757437

Group type: EXPERIMENTAL
Intervention: Wearable cardioverter-defibrillator (WCD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 34040607

Group type: EXPERIMENTAL
Intervention: MVA-HIV clade B vaccine (MVA-B)
Number of subjects: 0
Study: 32927677

Group type: EXPERIMENTAL
Intervention: Black soybean cookie (40 g daily, containing 20 g roasted black soybean powder)
Number of subjects: 22
Study: 35358820

Group type: EXPERIMENTAL
Intervention: Problem-Solving Skills Training (PSST)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Care as Usual (CAU)
Number of subjects: 50
Study: 33190843

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 32304981

Group type: EXPERIMENTAL
Intervention: Intramuscular or intranasal administration of naloxone
Number of subjects: 46
Study: 35653174

Group type: EXPERIMENTAL
Intervention: Student Bodies‐AN (SB‐AN) - intervention group (IG)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Wait-list control group (CG)
Number of subjects: 168
Study: 32202124

Group type: EXPERIMENTAL
Intervention: Dry needling combined with manual therapy (DN+MT)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Sham dry needling combined with manual therapy (SDN+MT)
Number of subjects: 101
Study: 34825704

Group type: COMPARATOR
Intervention: Active agent
Number of subjects: 0

Group type: COMPARATOR
Intervention: Censored, time-lagged categorical outcome
Number of subjects: 0
Study: 34192327

Group type: EXPERIMENTAL
Intervention: Glass fiber posts with direct composite
Number of subjects: 141

Group type: COMPARATOR
Intervention: Cast metal posts without crowns
Number of subjects: 141

Group type: COMPARATOR
Intervention: Glass fiber posts with crowns
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Composite restorations
Number of subjects: 141
Study: 32951600

Group type: EXPERIMENTAL
Intervention: Rural residence
Number of subjects: 1730

Group type: COMPARATOR
Intervention: Non-rural residence
Number of subjects: 1730
Study: 35500352

Group type: EXPERIMENTAL
Intervention: Testosterone administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 0
Study: 34720494

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.0055%)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Balanced Salt Solution (BSS)
Number of subjects: 49
Study: 33032123

Group type: EXPERIMENTAL
Intervention: Emergency Manual (EM) available during simulation
Number of subjects: 304
Study: 36175092

Group type: EXPERIMENTAL
Intervention: Film-forming skin protecting leave-on products
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Lipophilic skin protecting leave-on products
Number of subjects: 210

Group type: COMPARATOR
Intervention: Standard incontinence care alone
Number of subjects: 210
Study: 33522926

Group type: EXPERIMENTAL
Intervention: Training for ANC providers on person-centred communication (PCC) for FGM prevention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Provision of FGM-related clinical guidelines and handbook, anti-FGM policies and posters
Number of subjects: 60
Study: 33004705

Group type: EXPERIMENTAL
Intervention: 1% H2 inhalation during exercise
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 1% H2 inhalation during resting state
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control gas during exercise
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control gas during resting state
Number of subjects: 16
Study: 34529156

Group type: EXPERIMENTAL
Intervention: Nasal corticosteroid (NC) therapy + hyaluronic acid (HA) administered twice a day via nasal douche device (Group 3)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Nasal corticosteroid (NC) therapy + normal saline solution (NSS) administered twice a day (Group 2)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Nasal corticosteroid (NC) therapy only (Group 1)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Nasal corticosteroid (NC) therapy + hyaluronic acid (HA) (Group 3)
Number of subjects: 76
Study: 32366308

Group type: EXPERIMENTAL
Intervention: Virtual Clinical Pharmacy Service (VCPS) via telehealth
Number of subjects: 2080
Study: 36217922

Group type: EXPERIMENTAL
Intervention: School-based nutrition program (phase 1 only)
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: School-based nutrition program (both phases)
Number of subjects: 311
Study: 34694998

Group type: EXPERIMENTAL
Intervention: Cerebellar transcranial direct current stimulation (ctDCS) PhaseD
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cerebellar transcranial direct current stimulation (ctDCS) PhaseL
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cerebellar transcranial direct current stimulation (ctDCS) PhaseD and PhaseL
Number of subjects: 12
Study: 32393980

Group type: EXPERIMENTAL
Intervention: High-saturated-fat meal
Number of subjects: 51
Study: 35728220

Group type: EXPERIMENTAL
Intervention: Asthma intervention (12-month respiratory nurse-led asthma assessment and a class-based asthma education programme for four months)
Number of subjects: 675

Group type: COMPARATOR
Intervention: Control intervention (class-based science education programme for four months)
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: Asthma intervention
Number of subjects: 675

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 675
Study: 34767149

Group type: EXPERIMENTAL
Intervention: Combination of rectal diclofenac 100 mg and epinephrine spray (0.02%) on duodenal papilla (group A)
Number of subjects: 882

Group type: COMPARATOR
Intervention: Combination of rectal diclofenac 100 mg and saline spray on duodenal papilla (group B)
Number of subjects: 882
Study: 36442318

Group type: EXPERIMENTAL
Intervention: Lifestyle modification program (LMP)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo (written suggestions for lifestyle changes)
Number of subjects: 94
Study: 33416951

Group type: EXPERIMENTAL
Intervention: [18F]FDG PET/CT radiomics signature
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: [18F]FDG PET/CT radiomics nomogram (D-PET/CT model)
Number of subjects: 80
Study: 32446864

Group type: EXPERIMENTAL
Intervention: Reduced frequency BCG instillations (9 total instillations)
Number of subjects: 345

Group type: COMPARATOR
Intervention: Standard BCG instillations (15 total instillations)
Number of subjects: 345
Study: 34379922

Group type: EXPERIMENTAL
Intervention: Cabotegravir (CAB-LA) 600 mg intramuscularly every 8 weeks
Number of subjects: 4566

Group type: COMPARATOR
Intervention: Tenofovir disoproxil fumarate-emtricitabine (TDF-FTC) daily
Number of subjects: 4566
Study: 33218893

Group type: EXPERIMENTAL
Intervention: Housing First intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as Usual
Number of subjects: 0
Study: 32632661

Group type: EXPERIMENTAL
Intervention: Covered stents
Number of subjects: 0

Group type: COMPARATOR
Intervention: Uncovered stents
Number of subjects: 0
Study: 36375487

Group type: EXPERIMENTAL
Intervention: Rebamipide
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control (Proton Pump Inhibitor - Lansoprazole)
Number of subjects: 33
Study: 32461325

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 positive cases with anosmia or dysgeusia or both
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Presence of myalgia
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Blurred vision
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Chest pain
Number of subjects: 134
Study: 34314240

Group type: EXPERIMENTAL
Intervention: Aquablation
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Prostatic Urethral Lift (PUL)
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Transurethral Water Vapor Therapy (TWVT)
Number of subjects: 391
Study: 34257042

Group type: EXPERIMENTAL
Intervention: Budesonide prophylaxis (3 mg PO daily at day +5 post‐AHCT till discharge)
Number of subjects: 257

Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Budesonide prophylaxis
Number of subjects: 257
Study: 34344218

Group type: EXPERIMENTAL
Intervention: Individualized medical nutrition guidance
Number of subjects: 820

Group type: COMPARATOR
Intervention: Routine health education and nutrition guidance (Control)
Number of subjects: 820
Study: 32085844

Group type: EXPERIMENTAL
Intervention: Early parenteral nutrition
Number of subjects: 825

Group type: EXPERIMENTAL
Intervention: Early parenteral nutrition (specifically amino acids)
Number of subjects: 825

Group type: COMPARATOR
Intervention: Late parenteral nutrition
Number of subjects: 825
Study: 34228592

Group type: EXPERIMENTAL
Intervention: Ammonia inhalants (AI)
Number of subjects: 14
Study: 34770243

Group type: EXPERIMENTAL
Intervention: Unified Protocol (UP)
Number of subjects: 69
Study: 33198595

Group type: EXPERIMENTAL
Intervention: Cognitive Bias Modification of Interpretation (CBM-I)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Mindfulness Therapy
Number of subjects: 45

Group type: COMPARATOR
Intervention: No Treatment Control
Number of subjects: 45
Study: 32105522

Group type: EXPERIMENTAL
Intervention: High-pressure BFR-RE (30% 1RM at 80% pressure)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High-load RE (70% 1RM)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low-pressure BFR-RE (30% 1RM at 40% pressure)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: BFR-RE (both low and high pressure)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Light load resistance exercise with BFR
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: BFR-RE
Number of subjects: 12
Study: 36037830

Group type: EXPERIMENTAL
Intervention: Essen Stroke Risk Score (ESRS)
Number of subjects: 3441
Study: 32783769

Group type: EXPERIMENTAL
Intervention: Trial purified vero cell-cultured rabies vaccine (trial vaccine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Essen group (control vaccine)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zagreb group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups (Zagreb, Essen, control)
Number of subjects: 0
Study: 36085406

Group type: COMPARATOR
Intervention: Adult Eating Disorders program (n = 44)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Adult Intellectual Disability Mental Health program (n = 67)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: General Mental Health program (n = 28)
Number of subjects: 21
Study: 33289450

Group type: EXPERIMENTAL
Intervention: Aortic valve replacement in patients with reduced LVEF
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Aortic valve replacement in patients with preserved LVEF
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Preoperative early diastolic transmitral flow velocity/mitral annular tissue velocity ratio
Number of subjects: 280
Study: 36174280

Group type: EXPERIMENTAL
Intervention: Direct participant role (primary or secondary nurse)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Non-directed observer with no briefing or observer guide
Number of subjects: 193

Group type: COMPARATOR
Intervention: Direct observer with an observation guide
Number of subjects: 193

Group type: COMPARATOR
Intervention: In-scenario observer assigned to a non-clinical or other professional role
Number of subjects: 193
Study: 34024173

Group type: EXPERIMENTAL
Intervention: Caffeine (3 × 150 mg caffeine daily for 10 days)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Withdrawal (3 × 150 mg caffeine for 8 days then placebo)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 32195857

Group type: EXPERIMENTAL
Intervention: Internal fixation
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: External fixation
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Percutaneous pinning
Number of subjects: 304

Group type: COMPARATOR
Intervention: Casting
Number of subjects: 304
Study: 34289276

Group type: EXPERIMENTAL
Intervention: Dolutegravir + Lamivudine + Tenofovir
Number of subjects: 464

Group type: EXPERIMENTAL
Intervention: Darunavir + Lamivudine + Tenofovir
Number of subjects: 464

Group type: EXPERIMENTAL
Intervention: Tenofovir + Lamivudine
Number of subjects: 464

Group type: COMPARATOR
Intervention: Zidovudine + Lamivudine
Number of subjects: 464
Study: 32404908

Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 33531294

Group type: EXPERIMENTAL
Intervention: Positive parental myopia (PPM) group
Number of subjects: 113

Group type: COMPARATOR
Intervention: Negative parental myopia (NPM) group
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Overall axial length of young adult myopes with parental myopia
Number of subjects: 113

Group type: COMPARATOR
Intervention: Overall axial length of young adult myopes with non-myopic parents
Number of subjects: 113
Study: 34879822

Group type: EXPERIMENTAL
Intervention: High mean arterial pressure (H-MAP) group (target MAP between 70 and 80 mmHg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: High mean arterial pressure (H-MAP) group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low mean arterial pressure (L-MAP) group (target MAP between 50 and 60 mmHg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low mean arterial pressure (L-MAP) group
Number of subjects: 40
Study: 32616026

Group type: COMPARATOR
Intervention: Single dose of antibiotics at anesthesia induction (n = 73)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Antibiotics at anesthesia induction and for 24 hours (n = 73)
Number of subjects: 146
Study: 35130939

Group type: EXPERIMENTAL
Intervention: Neurological and Psycho-affective Early Childhood Development Program
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (non-intervened communities)
Number of subjects: 80
Study: 33010188

Group type: EXPERIMENTAL
Intervention: Ustekinumab (6 mg/kg intravenously at week 0, followed by 90 mg subcutaneously every 8 weeks)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 32071136

Group type: EXPERIMENTAL
Intervention: Airway clearance intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: No intervention (test-retest cohort)
Number of subjects: 60
Study: 35965680

Group type: EXPERIMENTAL
Intervention: Abdominal massage
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine massage
Number of subjects: 60
Study: 34334314

Group type: EXPERIMENTAL
Intervention: Transcutaneous oxygen pressure (tcpO2) measurement during endovascular intervention
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Systolic toe pressure (TP) measurement during endovascular intervention
Number of subjects: 21
Study: 33777303

Group type: EXPERIMENTAL
Intervention: Urban PHC workers
Number of subjects: 320

Group type: COMPARATOR
Intervention: Rural PHC workers
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Senior health workers
Number of subjects: 320

Group type: COMPARATOR
Intervention: Junior health workers
Number of subjects: 320
Study: 34284381

Group type: EXPERIMENTAL
Intervention: hUC-MSCs
Number of subjects: 10
Study: 34409727

Group type: EXPERIMENTAL
Intervention: Nutrition and gender behaviour change communication intervention
Number of subjects: 30
Study: 32648861

Group type: EXPERIMENTAL
Intervention: Coconut oil (1 tablespoon or 12 mL daily)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Soybean oil (control group)
Number of subjects: 29
Study: 35201827

Group type: EXPERIMENTAL
Intervention: Breath counting
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Distraction (cross counting)
Number of subjects: 278

Group type: COMPARATOR
Intervention: Stress-only
Number of subjects: 278

Group type: COMPARATOR
Intervention: No-stress
Number of subjects: 278
Study: 33605656

Group type: EXPERIMENTAL
Intervention: Open-label placebo (OLP)
Number of subjects: 262

Group type: COMPARATOR
Intervention: No-pill control (NPC)
Number of subjects: 262

Group type: COMPARATOR
Intervention: Double-blind placebo (DBP)
Number of subjects: 262
Study: 34186504

Group type: EXPERIMENTAL
Intervention: Experimental arm in discordant trials
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control arm in concordant trials
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Sensitivity analysis on discordant trials
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Sensitivity analysis on concordant trials
Number of subjects: 73
Study: 32453116

Group type: EXPERIMENTAL
Intervention: Goal Attainment Scaling (GAS) rehabilitation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard rehabilitation
Number of subjects: 120
Study: 33253017

Group type: EXPERIMENTAL
Intervention: Student-targeted contact video
Number of subjects: 163

Group type: COMPARATOR
Intervention: MH comparison contact video
Number of subjects: 163

Group type: COMPARATOR
Intervention: Non‐MH comparison video
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Student-targeted contact video among participants with preexisting psychological distress
Number of subjects: 163
Study: 34626840

Group type: EXPERIMENTAL
Intervention: BSHAPE intervention
Number of subjects: 70
Study: 32321651

Group type: EXPERIMENTAL
Intervention: Active treatment (TRPMS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 30
Study: 37585146

Group type: EXPERIMENTAL
Intervention: Dietary iron intake <18 mg/day
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Dietary iron intake 18-27 mg/day
Number of subjects: 206

Group type: COMPARATOR
Intervention: Dietary iron intake >27 mg/day (reference group)
Number of subjects: 206
Study: 32718692

Group type: EXPERIMENTAL
Intervention: Exercise plus testosterone (TEX)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Exercise plus placebo (PEX)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 26
Study: 36889611

Group type: COMPARATOR
Intervention: Prophylactic-dose enoxaparin
Number of subjects: 3398

Group type: EXPERIMENTAL
Intervention: Therapeutic-dose enoxaparin and therapeutic-dose apixaban
Number of subjects: 3398

Group type: EXPERIMENTAL
Intervention: Therapeutic-dose anticoagulation (therapeutic-dose enoxaparin and therapeutic-dose apixaban)
Number of subjects: 3398
Study: 33096121

Group type: EXPERIMENTAL
Intervention: Coordinative exercise (CE)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Cardiovascular exercise (CVE)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 135
Study: 35049134

Group type: EXPERIMENTAL
Intervention: SENSory relearning and task-specific training
Number of subjects: 27

Group type: COMPARATOR
Intervention: Task-specific training only (Control Group)
Number of subjects: 27
Study: 33611431

Group type: EXPERIMENTAL
Intervention: Systemic chemotherapy plus cTACE (arm A)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Systemic chemotherapy alone (arm B)
Number of subjects: 168
Study: 36066518

Group type: EXPERIMENTAL
Intervention: Individualized audit and feedback intervention (n=2933 GPs)
Number of subjects: 3660

Group type: COMPARATOR
Intervention: Control condition (no intervention) (n=727 GPs)
Number of subjects: 3660
Study: 35002817

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 37
Study: 35545343

Group type: EXPERIMENTAL
Intervention: IMB skills intervention
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (usual health care)
Number of subjects: 120
Study: 32573426

Group type: EXPERIMENTAL
Intervention: Ixekizumab (IXE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 0
Study: 33491266

Group type: EXPERIMENTAL
Intervention: Trochlear dysplasia knees
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Female experimental group (Group FE)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Low-grade dysplasia group
Number of subjects: 121

Group type: COMPARATOR
Intervention: Normal knees (Control group)
Number of subjects: 121
Study: 32247676

Group type: EXPERIMENTAL
Intervention: VIP protocol (dilute povidone-iodine lavage followed by application of vancomycin powder)
Number of subjects: 1413

Group type: COMPARATOR
Intervention: Historical control group (not treated with VIP)
Number of subjects: 1413

Group type: EXPERIMENTAL
Intervention: VIP protocol
Number of subjects: 1413
Study: 34369975

Group type: EXPERIMENTAL
Intervention: Smell and taste of milk with tube feeding
Number of subjects: 396

Group type: COMPARATOR
Intervention: Routine care without the provision of smell and taste of milk
Number of subjects: 396
Study: 32560938

Group type: EXPERIMENTAL
Intervention: dCBT‐I
Number of subjects: 358

Group type: COMPARATOR
Intervention: Control (online sleep education)
Number of subjects: 358